Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Why Are Stocks Up Today?
11:19am, Thursday, 27'th Apr 2023
Investors wondering why stocks are up today have a couple of pieces of news worth catching up on. First off, stocks are up today thanks to several large corporations releasing earnings reports.
Obesity Drug Hype Outweighs Profit Miss at Eli Lilly
11:12am, Thursday, 27'th Apr 2023
Mounjaro excitement more than makes up for company's first quarter results.
LLY Stock Alert: Mounjaro Takes Eli Lilly to the Next Level
10:13am, Thursday, 27'th Apr 2023
Eli Lilly (NYSE: LLY ) stock is climbing higher on Thursday thanks to a boost from Mounjaro during its earnings report for the first quarter of 2023. According to the company, diabetes drug Mounjaro s
Eli Lilly Pushes For Fast-Track Approval Of Mounjaro As Weight-Loss Drug
10:02am, Thursday, 27'th Apr 2023
Late-stage trials suggest Lilly's tirzepatide, sold under Mounjaro, could be a more effective obesity drug that Ozempic or Wegovy, and the company expects a regulatory decision by the end of the year.
Is Eli Lilly Stock a Strong Buy After Q1 Earnings?
09:25am, Thursday, 27'th Apr 2023
Shares have been on the volatile side this year due to a slew of headwinds. Over the long term, these headwinds will likely fade due to the growth potential of its rapidly emerging flagship drug, Moun
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
09:15am, Thursday, 27'th Apr 2023
Eli Lilly plans to complete its application for FDA approval of tirzepatide in the coming weeks and expects regulatory action as early as later this year.
Eli Lilly's Diabetes Newcomer, Mounjaro, Just Blew Sales Projections Out Of The Water
08:57am, Thursday, 27'th Apr 2023
Eli Lilly stock jumped Thursday on better-than-expected sales of diabetes newcomer, Mounjaro, helping offset a massive Covid-related decline. The post Eli Lilly's Diabetes Newcomer, Mounjaro, Just Ble
Eli Lilly misses on earnings but raises full-year guidance
08:07am, Thursday, 27'th Apr 2023
The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.
Eli Lilly stock up premarket as company's Q1 revenue beats and it raises guidance
07:01am, Thursday, 27'th Apr 2023
Eli Lilly & Co. shares LLY rose 2% premarket Thursday, after the company posted first-quarter earnings showing a revenue beat and raised its full-year guidance. The company posted net income of $1.345
Eli Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in late-stage trial
06:25am, Thursday, 27'th Apr 2023
Eli Lilly & Co. LLY said Thursday its tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in a late-stage trial. Participants in the phase 3 trial cal
Eli Lilly's Mounjaro Moves Toward Possible FDA Obesity Approval
06:15am, Thursday, 27'th Apr 2023
The company plans to finalize its application for FDA approval of its weight-loss drug tirzepatide, sold as Mounjaro.
Markets Continue Steady Slide; META, EBAY Beat Q1 Earnings
07:46pm, Wednesday, 26'th Apr 2023
Except the Nasdaq, which snapped a two-day losing streak and was the only major index in the green all day.
Eli Lilly Earnings Are Soon. All Eyes Are on Its Diabetes Drug.
04:30pm, Wednesday, 26'th Apr 2023
Expectations for first-quarter sales of its diabetes treatment, Mounjaro, are $433 million.
Why Eli Lilly Stock Is Under Pressure Today
01:20pm, Wednesday, 26'th Apr 2023
Eli Lilly is scheduled to report 2023 Q1 earnings tomorrow. Investors seem to be concerned that Wall Street's expectations are too high.
Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More
10:40am, Wednesday, 26'th Apr 2023
Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.
